UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Epstein–Barr virus-associated gastric cancer: disease that requires special approach

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-11, Vol.23 (6), p.951-960

2020

Volltextzugriff (PDF)

Second-line treatment of metastatic gastric cancer:Current options and future directions

World journal of gastroenterology : WJG, 2015-11, Vol.21 (41), p.11621-11635

2015

Volltextzugriff (PDF)

Case Report: Progressive disease of BRCA2-mutant colon adenocarcinoma following talazoparib therapy

Frontiers in oncology, 2023-11, Vol.13

2023

Volltextzugriff (PDF)

Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy

Cancers, 2023-04, Vol.15 (8), p.2288

2023

Volltextzugriff (PDF)

Detecting Microsatellite Instability in Endometrial, Colon, and Stomach Cancers Using Targeted NGS

Cancers, 2023-10, Vol.15 (20), p.5065

2023

Volltextzugriff (PDF)

Role of Stem Cells in Colorectal Cancer Progression and Prognostic and Predictive Characteristics of Stem Cell Markers in Colorectal Cancer

Current stem cell research & therapy, 2017-01, Vol.12 (1), p.19

2017

Volltextzugriff (PDF)

Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results

Clinical and experimental medicine, 2023-10, Vol.23 (6), p.2663-2674

2023

Volltextzugriff (PDF)

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Clinical colorectal cancer, 2019-09, Vol.18 (3), p.183-191.e3

2019

Volltextzugriff (PDF)

Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experience

Heliyon, 2024-05, Vol.10 (9), p.e30303-e30303, Article e30303

2024

Volltextzugriff (PDF)

Alternative allele frequency recallibration after NGS data analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3077-3077

2023

Volltextzugriff (PDF)

Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study

Japanese journal of clinical oncology, 2016-07, Vol.46 (7), p.610-614

2016

Volltextzugriff (PDF)

Comprehensive multigene profiling impact on clinical decisions in patients with advanced cancers: A multicenter, retrospective analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15163-e15163

2023

Volltextzugriff (PDF)

Started dose of regorafenib and overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): A systematic review and meta-analysis

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.131-131

2020

Volltextzugriff (PDF)

Prognosis of patients with resected stage II colon cancer -T4 versus T3 with two or more high-risk factors: A retrospective single-center cohort study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15608-e15608

2022

Volltextzugriff (PDF)

Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e17551-e17551

2022

Volltextzugriff (PDF)

Addition of anti-PD1 antibodies to chemotherapy (CT) in first-line treatment of advanced esophageal cancer (EC): A systematic review and meta-analysis

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16055-e16055

2022

Volltextzugriff (PDF)

Late relapses (>2 years) in patients with stage I testicular germ cell tumors: Predictive factors and survival

Urologic oncology, 2013-05, Vol.31 (4), p.499-504

2013

Volltextzugriff (PDF)

Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis

Urologic oncology, 2014, Vol.32 (1), p.32.e27-32.e33

2014

Volltextzugriff (PDF)

Efficacy of first-line treatments for patients (pts) with advanced EGFR mutated NSCLC: Network meta-analysis of TKI monotherapy and combinations trials

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e21120-e21120

2021

Volltextzugriff (PDF)

Is antiangiogenic therapy necessary for patients with metastatic colorectal cancer (mCRC) and mutation in the BRAF gene? Results of the systematic review and meta-analysis

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.88-88

2021

Volltextzugriff (PDF)

Importance of critical evaluation of genomic findings reported following comprehensive tumor molecular profiling (CTMP) for discussion within molecular tumor boards (MTB)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18623-e18623

2022

Volltextzugriff (PDF)

“Interchangeability” of anti-PD1 antibodies in patients (pts) with metastatic melanoma (mM)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e21546-e21546

2023

Volltextzugriff (PDF)

Results of a retrospective multicenter study comparing the effectiveness of regorafenib and the rechallenge of chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15561-e15561

2023

Volltextzugriff (PDF)

Efficacy of platinum-based chemotherapy in platinum-resistant ovarian cancer: A systematic review with pooled analysis of outcomes

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18076-e18076

2020

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(106)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(26)
Physical Sciences
(24)
Oncology
(23)
Humans
(13)
Physics
(13)
Physics, Applied
(12)
Prognosis
(12)
Male
(11)
Chemistry
(10)
Chemotherapy
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Medicine
(9)
Medicine & Public Health
(9)
Adult
(8)
Colorectal Cancer
(7)
Retrospective Studies
(7)
Cancer Research
(6)
Middle Aged
(6)
Tumors
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Epstein–Barr virus-associated gastric cancer: disease that requires special approach

Second-line treatment of metastatic gastric cancer:Current options and future directions

Case Report: Progressive disease of BRCA2-mutant colon adenocarcinoma following talazoparib therapy

Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy

Detecting Microsatellite Instability in Endometrial, Colon, and Stomach Cancers Using Targeted NGS

Role of Stem Cells in Colorectal Cancer Progression and Prognostic and Predictive Characteristics of Stem Cell Markers in Colorectal Cancer

Utility of public knowledge bases for the interpretation of comprehensive tumor molecular profiling results

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)

Evidence blocks for effective presentation of genomic findings at molecular tumor boards: Single institution experience

Alternative allele frequency recallibration after NGS data analysis

Preoperative chemotherapy in patients with resectable esophageal carcinoma: a single center Phase II study

Comprehensive multigene profiling impact on clinical decisions in patients with advanced cancers: A multicenter, retrospective analysis

Started dose of regorafenib and overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): A systematic review and meta-analysis

Prognosis of patients with resected stage II colon cancer -T4 versus T3 with two or more high-risk factors: A retrospective single-center cohort study

Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis

Addition of anti-PD1 antibodies to chemotherapy (CT) in first-line treatment of advanced esophageal cancer (EC): A systematic review and meta-analysis

Late relapses (>2 years) in patients with stage I testicular germ cell tumors: Predictive factors and survival

Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis

Efficacy of first-line treatments for patients (pts) with advanced EGFR mutated NSCLC: Network meta-analysis of TKI monotherapy and combinations trials

Is antiangiogenic therapy necessary for patients with metastatic colorectal cancer (mCRC) and mutation in the BRAF gene? Results of the systematic review and meta-analysis

Importance of critical evaluation of genomic findings reported following comprehensive tumor molecular profiling (CTMP) for discussion within molecular tumor boards (MTB)

“Interchangeability” of anti-PD1 antibodies in patients (pts) with metastatic melanoma (mM)

Results of a retrospective multicenter study comparing the effectiveness of regorafenib and the rechallenge of chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC)

Efficacy of platinum-based chemotherapy in platinum-resistant ovarian cancer: A systematic review with pooled analysis of outcomes

Suchergebnisse filtern